Automatic Website Traffic RSS


US   France   Germany   Spain   Netherlands  

Interferon Beta | AutoTraffic

Interferon Beta Drugs for Multiple Sclerosis

Your body makes interferons naturally. Three forms -- alpha, beta, and gamma -- control the activity of your immune system. But doctors also can use a man-made ... read more

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The annualized relapse rate was lower with daclizumab HYP than with interferon beta-1a (0.22 vs. 0.39; 45% lower rate with daclizumab HYP; P<0.001). The number of new or newly enlarged ... read more

Dose and Frequency of Administration of Interferon-Beta Affect its Efficacy in Multiple Sclerosis

Data reviewed in this article demonstrate that both interferon-ß-1a (IFNß-1a) and interferon-ß-1b (IFNß-1b) show a dose-response relationship in multiple sclerosis at current clinical doses. read more

Navigating the maze of cancer: How precision medicine unravels the unknown

In our journey to unravel the obscurities of high-grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), we've embarked on a quest guided by personalized medicine principles. Imagine you're ... read more

interferon beta-1a

This page shows the latest interferon beta-1a news and features for those working in and with pharma, biotech and healthcare. This was done to encourage HCPs to prescribe the MS drugs Avonex ... read more

How interferon beta protein treatment helps fight coronavirus

The company's CEO, Richard Marsden, explained how the treatment uses a protein called interferon beta, which our bodies produce to help fight viral infections. The results have not been published ... read more

Multiple Sclerosis : What Is It & Treatments

Overview A disease that affects central nervous system. The immune system attacks the myelin, the protective layer around nerve fibers and causes Inflammation and lesions. This makes it difficult for ... read more

Global Interferons Market Poised for Remarkable Growth, Reaching US$ 13.8 Billion by 2032

The global interferons market is set to embark on a remarkable growth trajectory, with a projected valuation of US$ 13.8 billion by the conclusion of 2032. This revelation stems from the latest ... read more

Ozanimod Controls MS Disease Activity Regardless of Age

Ozanimod was approved to treat RMS in 2020 based on data from the pivotal SUNBEAM and RADIANCE studies, which showed lower relapse rates with ozanimod compared with interferon beta-1a. Patients ... read more

Room-temperature Storage of Medications Labeled for Refrigeration

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Pediarix (GlaxoSmithKline) 24 hr Manufacturer Diphtheria and ... read more

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

The primary end point was the annualized relapse rate. The annualized relapse rate was lower with daclizumab HYP than with interferon beta-1a (0.22 vs. 0.39; 45% lower rate with daclizumab HYP ... read more
Subscribe to RSS Feed

Auto Traffic generator Powered by. Full RSS Feed | Article Generator | Contact Us